Justin Bowers
Stock Analyst at Wells Fargo
(1.89)
# 3,222
Out of 5,058 analysts
42
Total ratings
37.5%
Success rate
4.36%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FLUT Flutter Entertainment | Initiates: Overweight | $272 | $193.27 | +40.74% | 1 | Nov 18, 2025 | |
| DKNG DraftKings | Initiates: Equal-Weight | $31 | $29.02 | +6.82% | 1 | Nov 18, 2025 | |
| WAT Waters | Maintains: Hold | $375 → $315 | $376.25 | -16.28% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $592.18 | -27.39% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $217.48 | +21.85% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $10.04 | +129.08% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $19.23 | +50.81% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $15.65 | +59.74% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $155.08 | -0.05% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $573.79 | +6.31% | 3 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $82 | $57.81 | +41.84% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $11.01 | +127.07% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.50 | +385.71% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $158.81 | +88.90% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $222.41 | +23.65% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $257.90 | -3.06% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $161.64 | +79.41% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $12.81 | +259.09% | 5 | May 10, 2021 |
Flutter Entertainment
Nov 18, 2025
Initiates: Overweight
Price Target: $272
Current: $193.27
Upside: +40.74%
DraftKings
Nov 18, 2025
Initiates: Equal-Weight
Price Target: $31
Current: $29.02
Upside: +6.82%
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $376.25
Upside: -16.28%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $592.18
Upside: -27.39%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $217.48
Upside: +21.85%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $10.04
Upside: +129.08%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $19.23
Upside: +50.81%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $15.65
Upside: +59.74%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $155.08
Upside: -0.05%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $573.79
Upside: +6.31%
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $57.81
Upside: +41.84%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $11.01
Upside: +127.07%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.50
Upside: +385.71%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $158.81
Upside: +88.90%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $222.41
Upside: +23.65%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $257.90
Upside: -3.06%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $161.64
Upside: +79.41%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $12.81
Upside: +259.09%